Different expressions of Nogo-B1 and Nogo-B2 in mouse heart microvascular endothelial cell dysfunction induced by lysophosphatidylcholine

Microvascular Research

Volumn 72, Issue 1-2, 2006, Pages 42-47

  Pan, Jing Wei ^a,b   Zheng, Xing ^a   Yang, Peng Yuan ^b   Qin, Yong Wen ^a   Rui, Yao Cheng ^b   Ma, Li Ping ^a   Zhou, Fei ^a   Kang, Hui ^b  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Endothelial cells; Lysophosphatidylcholine; Nogo B

Indexed keywords

LYSOPHOSPHATIDYLCHOLINE; MESSENGER RNA; PROTEIN NOGO; PROTEIN NOGO B1; PROTEIN NOGO B2; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL DAMAGE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; GENE CONTROL; GENE EXPRESSION REGULATION; HEART; INCUBATION TIME; MICROVASCULATURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION; UPREGULATION; VASCULAR ENDOTHELIUM; WESTERN BLOTTING;

ANIMALS; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION; LYSOPHOSPHATIDYLCHOLINES; MICE; MYELIN PROTEINS; MYOCARDIUM; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSCRIPTION, GENETIC;

EID: 33746379274     PISSN: 00262862     EISSN: 10959319     Source Type: Journal    
DOI: 10.1016/j.mvr.2006.05.004     Document Type: Article

References (21)

1. Acevedo L., Yu J., Erdjument-Bromage H., Miao R.Q., Kim J.E., Fulton D., Tempst P., Strittmatter S.M., and Sessa W.C. A new role for nogo as a regulator of vascular remodeling. Nat. Med. 10 4 (2004) 382-388
2. Amagasa H., Okazaki M., Iwai S., Kumai T., Kobayashi S., and Oguchi K. Enhancement of the coagulation system in spontaneously hypertensive and hyperlipidemic rats. J. Atheroscler. Thromb. 12 4 (2005) 191-198
3. Dodd D.A., Niederoest B., Bloechlinger S., Dupuis L., Loeffler J.P., and Schwab M.E. Nogo-A, -B, and -C are found on the cell surface and interact together in many different cell types. J. Biol. Chem. 280 13 (2005) 12494-12502
4. Frank G.D., Eguchi S., and Motley E.D. The role of reactive oxygen species in insulin signaling in the vasculature. Antioxid. Redox Signal. 7 7-8 (2005) 1053-1061
5. GrandPre T., Nakamura F., Vartanian T., and Smitrittmater S.M. Identification of the Nogo inhibitor of axon regeneration as a Reticulon protein. Nature 403 6768 (2000) 439-444
6. Hong Z., Ju fang Y., Jian Z., He T., and Xiao-Ping G. A new method of cyclooxygenase assay-semi-quantitative RT-PCR. J. Sichuan Univ. 39 (2002) 138-141
7. Huber A.B., Weinmann O., Broamle C., Oertle T., and Schwab M.E. Patterns of Nogo mRNA and protein expression in the developing and adult rat and after CNS lesions. J. Neurosci. 22 9 (2002) 3367-3553
8. Jokic N., Gonzalez de Auguilar J.L., Pradat P.F., Dupius L., Echaniz-Laguna A., Muller A., Dubourg O., Seilhean D., Hauw J.J., Leoffler J.P., and Meininger V. Nogo expression in muscle correlates with amyotrophic lateral sclerosis severity. Ann. Neurol. 57 4 (2005) 553-556
9. Josephson A., Trifunovski A., Widmer H.R., Widernfalk J., Olson L., and Spenger C. Nogo-receptor gene activity: cellular localization and developmental regulation of mRNA in mice and humans. J. Comp. Neurol. 453 3 (2002) 292-304
10. Kim J.E., Li S., Grandpre T., Qiu D., and Strittmatter S.M. Axon regeneration in young adult mice lacking NogoA/B. Neuron 38 2 (2003) 187-199
11. Magnusson C., Libelius R., and Tagerud S. Nogo (Reticulon 4) expression in innervated and denervated mouse skeletal muscle. Mol. Cell. Neurosci. 22 3 (2003) 298-307
12. Makowski L., and Hotamisligil G.S. The role of fatty acid binding proteins in metabolic syndrome and atherosclerosis. Curr. Opin. Lipidol. 16 5 (2005) 543-548
13. Meier S., Brauer A.U., Heimrich B., Schwab M.E., Nitsch R., and Savaskan N.E. Molecular analysis of Nogo expression in the hippocampus during development and following lesion and seizure. FASEB J. 17 9 (2003) 1153-1155
14. Oertle T., Huber C., van der Putten H., and Schwab M.E. Genomic structure and functional characterisation if the promoters of human and mouse nogo/rtn4. J. Mol. Biol. 325 2 (2003) 299-323
15. Ryborg A.K., Johansen C., Iversen L., and Kragballe K. Lysophosphatidylcholine induces keratinocyte differentiation and upregulation of AP-1- and NF-kappaB DNA-binding activity. Acta Derm.-Venereol. 84 6 (2004) 433-438
16. Safaya R., Chai H., Kougias P., Lin P., Lumsden A., Yao Q., and Chen C. Effect of lysophosphatidylcholine on vasomotor functions of porcine coronary arteries. J. Surg. Res. 126 2 (2005) 182-188
17. Satoh J.I., and Kuroda Y. Cytokines and neurotrophic factors fail to affect Nogo-A mRNA expression in differentiated human neurones: implications for inflammation-related axonal regeneration in the central nervous system. Neuropathol. Appl. Neurobiol. 28 2 (2002) 95-106
18. Simonen M., Pedersen V., Weinmann O., Schnell L., Buss A., Ledermann B., Christ F., Sansig G., van der Putten H., and Schwab M.E. Systemic deletion of the myolin-associated outgrowth inhibitor Nogo-A improves regenerative and plastic responses after spinal cord injury. Neuron 38 2 (2003) 201-211
19. Van Aalst J.A., Zhang D.M., Miyazaki K., Colles S.M., Fox P.L., and Granham L.M. Role of reactive oxygen species in inhibition of endothelial cell migration by oxidized low-density lipoprotein. J. Vasc. Surg. 40 6 (2004) 1208-1215
20. Yao Y., Ni Z., Zhang Y., Chen Y., Ding Y., Han Z., Liu Z., and Sun Q. Identification of differentially expressed genes in leaf and root between wheat hybrid and its parental inbreds using PCR-based cDNA subtraction. Plant Mol. Biol. 58 3 (2005) 367-384
21. Zhang X.M., Kimura Y., and Inui M. Effects of phospholipids on the oligomeric state of phospholamban of the cardiac sarcoplasmic reticulum. Circ. J. 69 9 (2005) 1116-1123